Impulse control disorders in Parkinson's disease: Seeking a roadmap toward a better understanding

Brain Structure and Function

Volumn 216, Issue 4, 2011, Pages 289-299

  Cilia, Roberto ^a   Van Eimeren, Thilo ^b,c  

^a PARKINSON INSTITUTE   (Italy)

^b NeuroImage Nord   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Addiction; Compulsive; Dopamine agonist; Gambling; Imaging; Impulsive

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; OPIATE ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; COGNITION; DOPAMINE RELEASE; DRUG DEPENDENCE; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; IMPULSE CONTROL DISORDER; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROBIOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NEUROPHYSIOLOGY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERSONALITY; PREVALENCE; PRIORITY JOURNAL; REINFORCEMENT; REWARD; RISK ASSESSMENT; RISK FACTOR; SYNAPSE;

AGE OF ONSET; APPETITIVE BEHAVIOR; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MODELS, BIOLOGICAL; NEUROIMAGING; PARKINSON DISEASE; PERSONALITY; SEX FACTORS; SUBTHALAMIC NUCLEUS;

EID: 84655176460     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-011-0314-0     Document Type: Article

References (141)

1. Alessi SM, Petry NM (2003) Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behav Processes 64:345-354 (Pubitemid 37324378)
2. Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H, Pelissolo A, Moro E, Lhommee E, Lang AE, Agid Y, Benabid AL, Pollak P, Mallet L, Krack P (2006) Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 21:1941-1946 (Pubitemid 44848942)
3. Bach JP, Oertel WH, Dodel R, Jessen F (2009) Treatment of hypersexuality in Parkinson's disease with carbamazepine-A case report. Mov Disord 24:1241-1242
4. Baler RD, Volkow ND (2006) Drug addiction: The neurobiology of disrupted self-control. Trends Mol Med 12:559-566 (Pubitemid 44780200)
5. Bandini F, Primavera A, Pizzorno M, Cocito L (2007) Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease. Parkinsonism Relat Disord 13:369-371 (Pubitemid 47212785)
6. Bermejo PE, Ruiz-Huete C, Anciones B (2010) Zonisamide in managing impulse control disorders in Parkinson's disease. J Neurol 257:1682-1685
7. Berridge KC, Robinson TE (2003) Parsing reward. Trends Neurosci 26:507-513 (Pubitemid 37025790)
8. Bienfait KL, Menza M, Mark MH, Dobkin RD (2010) Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists. J Clin Neurosci 17:539-540
9. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE (1995) Dopamine D2 receptor gene variants: Association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics 5(3):121-141
10. Bodi N, Keri S, Nagy H, Moustafa A, Myers CE, Daw N, Dibo G, Takats A, Bereczki D, Gluck MA (2009) Reward-learning and the novelty-seeking personality: A between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 132:2385-2395
11. Bonfanti AB, Gatto EM (2010) Kleptomania, an unusual impulsive control disorder in Parkinson's disease? Parkinsonism Relat Disord 16:358-359
12. Brand M, Kalbe E, Labudda K, Fujiwara E, Kessler J, Markowitsch HJ (2005) Decision-making impairments in patients with pathological gambling. Psychiatry Res 133:91-99 (Pubitemid 40215475)
13. Brewer JA, Potenza MN (2008) The neurobiology and genetics of impulse control disorders: Relationships to drug addictions. Biochem Pharmacol 75:63-75 (Pubitemid 350235392)
14. Cilia R, Siri C, Marotta G, Isaias IU, De Gaspari D, Canesi M, Pezzoli G, Antonini A (2008) Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 65:1604-1611
15. Cilia R, Ko JH, Cho SS, van Eimeren T, Marotta G, Pellecchia G, Pezzoli G, Antonini A, Strafella AP (2010) Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling. Neurobiol Dis 39:98-104
16. Cilia R, Cho SS, van Eimeren T, Marotta G, Siri C, Ko JH, Pellecchia G, Pezzoli G, Antonini A, Strafella AP (2011) Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: A path modeling analysis. Mov Disord 26:225-233
17. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC (2004) Cognitive inflexibility after prefrontal serotonin depletion. Science 304:878-880 (Pubitemid 38620188)
18. Comings DE, Rosenthal RJ, Lesieur HR, Rugle LJ, Muhleman D, Chiu C et al (1996) A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 6(3):223-234 (Pubitemid 26226314)
19. Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D et al (1997) Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 2(1):44-56 (Pubitemid 27163110)
20. Comings DE, Gonzalez N, Wu S, Gade R, Muhleman D, Saucier G et al (1999) Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet 88(4):358-368 (Pubitemid 29372249)
21. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Chen C et al (2001) The additive effect of neurotransmitter genes in pathological gambling. Clin Genet 60(2):107-116 (Pubitemid 32791664)
22. Cools R, Robbins TW (2004) Chemistry of the adaptive mind. Philos Transact A Math Phys Eng Sci 362:2871-2888 (Pubitemid 40004422)
23. Cools R, Altamirano L, D'Esposito M (2006) Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia 44:1663-1673 (Pubitemid 43928015)
24. Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH (2010) Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: A case-control study. Sleep 33:81-87
25. Crockford D, Quickfall J, Currie S, Furtado S, Suchowersky O, El- Guebaly N (2008) Prevalence of problem and pathological gambling in Parkinson's disease. J Gambl Stud 24:411-422
26. da Silva Lobo DS, Vallada HP, Knight J, Martins SS, Tavares H, Gentil V, Kennedy JL (2007) Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud 23(4):421-433
27. Dalley JW, Everitt BJ, Robbins TW (2011) Impulsivity, compulsivity, and top-down cognitive control. Neuron 69:680-694
28. de Ruiter MB, Veltman DJ, Goudriaan AE, Oosterlaan J, Sjoerds Z, van den BrinkW(2009) Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problemgamblers and smokers. Neuropsychopharmacology 34:1027-1038
29. Devor EJ, Magee HJ, Dill-Devor RM, Gabel J, Black DW (1999) Serotonin transporter gene (5-HTT) polymorphisms and compulsive buying. Am J Med Genet 88(2):123-125 (Pubitemid 29156447)
30. Dewey RB Jr (2010) Pathological gambling in PD: Did the devil make me do it? Neurology 75:1668-1669
31. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF (2009) Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci USA 13 106(2):617-622 Epub 2008 Dec 22
32. Driver-Dunckley E, Samanta J, Stacy M (2003) Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 61:422-423 (Pubitemid 36975988)
33. Eisenegger C, Knoch D, Ebstein RP, Gianotti LR, Sándor PS, Fehr E (2010) Dopamine receptor D4 polymorphism predicts the effect of L-DOPA on gambling behavior. Biol Psychiatry 67(8):702-706
34. Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome. Mov Disord 19:397-405 (Pubitemid 38559642)
35. Evans AH, Strafella AP, Weintraub D, Stacy M (2009) Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord 24:1561-1570
36. Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR (2009) Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14:60-70
37. Forbush KT, Shaw M, Graeber MA, Hovick L, Meyer VJ, Moser DJ, Bayless J, Watson D, Black DW (2008) Neuropsychological characteristics and personality traits in pathological gambling. CNS Spectr 13:306-315 (Pubitemid 351656252)
38. Frank MJ, Seeberger LC, O'Reilly RC (2004) By carrot or by stick: Cognitive reinforcement learning in parkinsonism. Science 306:1940-1943 (Pubitemid 39627859)
39. Frank MJ, Samanta J, Moustafa AA, Sherman SJ (2007) Hold your horses: Impulsivity, deep brain stimulation, and medication in parkinsonism. Science 318:1309-1312 (Pubitemid 350172897)
40. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A (2007) Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 22:1757-1763 (Pubitemid 47597599)
41. Galpern WR, Stacy M (2007) Management of impulse control disorders in Parkinson's disease. Curr Treat Options Neurol 9:189-197 (Pubitemid 46736341)
42. Gelernter J, Kranzler H, Coccaro E, Siever L, New A, Mulgrew CL (1997) D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. Am J Hum Genet 61(5):1144-1152 (Pubitemid 27492324)
43. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ, Kranzler HR, Farrer L (2006) Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet 15(24):3498-3507 (Pubitemid 44884117)
44. Gerschlager W, Bloem BR (2009) Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions. Mov Disord 24:1858-1860
45. Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642-1652
46. Goldstein RZ, Tomasi D, Alia-Klein N, Cottone LA, Zhang L, Telang F, Volkow ND (2007) Subjective sensitivity to monetary gradients is associated with frontolimbic activation to reward in cocaine abusers. Drug Alcohol Depend 87:233-240 (Pubitemid 46215930)
47. Gotham AM, Brown RG, Marsden CD (1988) 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 111(Pt 2):299-321
48. Goto Y, Grace AA (2005) Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci 8:805-812 (Pubitemid 43085848)
49. Goto Y, Otani S, Grace AA (2007) The Yin and Yang of dopamine release: A new perspective. Neuropharmacology 53:583-587 (Pubitemid 47516678)
50. Goudriaan AE, Oosterlaan J, de Beurs E, Van den Brink W (2004) Pathological gambling: A comprehensive review of biobehavioral findings. Neurosci Biobehav Rev 28:123-141 (Pubitemid 38692361)
51. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W (2005) Decision making in pathological gambling: A comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Res Cogn Brain Res 23:137-151 (Pubitemid 40417513)
52. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W (2006) Neurocognitive functions in pathological gambling: A comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction 101:534-547 (Pubitemid 43375617)
53. Goudriaan AE, Slutske WS, Krull JL, Sher KJ (2009) Longitudinal patterns of gambling activities and associated risk factors in college students. Addiction 104:1219-1232
54. Grant JE, Kim SW, Potenza MN (2003) Advances in the pharmacological treatment of pathological gambling. J Gambl Stud 19:85-109 (Pubitemid 39012875)
55. Grosset KA, Grosset DG, Macphee G, Pal G, Stewart D, Watt A, Davie J (2007) Dopamine agonists and pathological gambling. Parkinsonism Relat Disord 13:259 (author reply 260) (Pubitemid 46603033)
56. Guo G, Tong Y, Xie CW, Lange LA (2007) Dopamine transporter, gender, and number of sexual partners among young adults. Eur J Hum Genet 15(3):279-287
57. Hahn T, Heinzel S, Dresler T, Plichta MM, Renner TJ, Markulin F et al (2010) Association between reward-related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype. Hum Brain Mapp. doi:10.1002/ hbm.21127. [Epub ahead of print]
58. Haile CN, Kosten TR, Kosten TA (2007) Genetics of dopamine and its contribution to cocaine addiction. Behav Genet 37:119-145 (Pubitemid 46144054)
59. Halbig TD, Tse W, Frisina PG, Baker BR, Hollander E, Shapiro H, Tagliati M, Koller WC, Olanow CW (2009) Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur J Neurol 16:493-497
60. Hampton AN, Adolphs R, Tyszka MJ, O'Doherty JP (2007) Contributions of the amygdala to reward expectancy and choice signals in human prefrontal cortex. Neuron 55:545-555 (Pubitemid 47225198)
61. Hemmings SM, Kinnear CJ, Lochner C, Seedat S, Corfield VA, Moolman-Smook JC, Stein DJ (2006) Genetic correlates in trichotillomania-a case-control association study in the South African Caucasian population. Isr J Psychiatry Relat Sci 43(2):93-101 (Pubitemid 44090651)
62. Hersrud SL, Stoltenberg SF (2009) Epistatic interaction between COMT and DAT1 genes on eating behavior: A pilot study. Eat Behav 10(2):131-133
63. Hewig J, Straube T, Trippe RH, Kretschmer N, Hecht H, Coles MG, Miltner WH (2009) Decision-making under risk: An fMRI study. J Cogn Neurosci 21:1642-1652
64. Hoeft F, Watson CL, Kesler SR, Bettinger KE, Reiss AL (2008) Gender differences in the mesocorticolimbic system during computer game-play. J Psychiatr Res 42:253-258
65. Hollander E, Pallanti S, Baldini Rossi N, Sood E, Baker BR, Buchsbaum MS (2005) Imaging monetary reward in pathological gamblers. World J Biol Psychiatry 6:113-120 (Pubitemid 40895135)
66. Hollander E, Buchsbaum, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, Goodman CR, LiCalzi EM, Newmark R, Pallanti S (2008) FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology 58:37-47
67. Holman AJ (2009) Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia. J Gambl Stud 25:425-431
68. Hyman SE (2005) Addiction: A disease of learning and memory. Am J Psychiatry 162:1414-1422 (Pubitemid 41105555)
69. Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: The role of reward-related learning and memory. Annu Rev Neurosci 29:565-598 (Pubitemid 44476856)
70. Ibañez A, Perez De Castro I, Fernandez-Piqueras J, Blanco C, Saiz-Ruiz J (2000) Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Mol Psychiatry 5(1):105-109 (Pubitemid 30088461)
71. Ikemoto S, Kohl RR, McBride WJ (1997) GABA(A) receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J Neurochem 69(1):137-143 (Pubitemid 27274166)
72. Jimenez-Murcia S, Alvarez-Moya EM, Stinchfield R, Fernandez- Aranda F, Granero R, Aymami N, Gomez-Pena M, Jaurrieta N, Bove F, Menchon JM (2010) Age of onset in pathological gambling: Clinical, therapeutic and personality correlates. J Gambl Stud 26:235-248
73. Jocham G, Klein TA, Neumann J, von Cramon DY, Reuter M, Ullsperger M (2009) Dopamine DRD2 polymorphism alters reversal learning and associated neural activity. J Neurosci 29:3695-3704
74. Kalechstein AD, Fong T, Rosenthal RJ, Davis A, Vanyo H, Newton TF (2007) Pathological gamblers demonstrate frontal lobeimpairment consistent with that of methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci 19:298-303 (Pubitemid 47293903)
75. Kalivas PW, Volkow ND (2005) The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 162:1403-1413 (Pubitemid 41105554)
76. Kertzman S, Lowengrub K, Aizer A, Vainder M, Kotler M, Dannon PN (2008) Go-no-go performance in pathological gamblers. Psychiatry Res 161:1-10
77. Kim JH, Park M, Yang SY, Jeong BS, Yoo HJ, Kim JW et al (2006) Association study of polymorphisms in N-methyl-D-aspartate receptor 2B subunits (GRIN2B) gene with Korean alcoholism. Neurosci Res 56(2):220-223 (Pubitemid 44389884)
78. Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318:876-880 (Pubitemid 18090271)
79. Knutson B, Cooper JC (2005) Functional magnetic resonance imaging of reward prediction. Curr Opin Neurol 18:411-417 (Pubitemid 41104804)
80. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8(11):1450-1457 (Pubitemid 41573655)
81. Labudda K, Wolf OT, Markowitsch HJ, Brand M (2007) Decisionmaking and neuroendocrine responses in pathological gamblers. Psychiatry Res 153:233-243 (Pubitemid 47632802)
82. Lakey CE, Goodie AS, Campbell WK (2006) Frequent card playing and pathological gambling: The utility of the Georgia gambling task and iowa gambling task for predicting pathology. J Gambl Stud [Epub ahead of print]
83. Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, Jeon BS (2009) Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov Disord 15 24(12):1803-1810
84. Lee JY, Kim JM, Kim JW, Cho J, Lee WY, Kim HJ, Jeon BS (2010) Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 16:202-207
85. Leiserson V, Pihl RO (2007) Reward-sensitivity, inhibition of rewardseeking, and dorsolateral prefrontal working memory function in problem gamblers not in treatment. J Gambl Stud 23:435-455
86. Leung KS, Cottler LB (2009) Treatment of pathological gambling. Curr Opin Psychiatry 22:69-74
87. Levitan RD, Masellis M, Basile VS, Lam RW, Kaplan AS, Davis C et al (2004) The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: An evolutionary perspective. Biol Psychiatry 56(9):665-669 (Pubitemid 39446848)
88. Lim SY, O'Sullivan SS, Kotschet K, Gallagher DA, Lacey C, Lawrence AD, Lees AJ, O'Sullivan DJ, Peppard RF, Rodrigues JP, Schrag A, Silberstein P, Tisch S, Evans AH (2009) Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 16:1148-1152
89. Lohoff FW, Weller AE, Bloch PJ, Nall AH, Ferraro TN, Kampman KM et al (2008) Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology 33(13):3078-3084
90. Marazziti D, Catena Dell'osso M, Conversano C, Consoli G, Vivarelli L, Mungai F, Di Nasso E, Golia F (2008) Executive function abnormalities in pathological gamblers. Clin Pract Epidemiol Ment Health 4:7
91. Moreno M, Cardona D, Gomez MJ, Sanchez-Santed F, Tobeña A, Fernandez-Teruel A, Campa L, Suñol C, Escarabajal MD, Torres C, Flores P (2010) Impulsivity characterization in the Roman highand low-avoidance rat strains: Behavioral and neurochemical differences. Neuropsychopharmacology 35:1198-1208
92. Moro E (2009) Impulse control disorders and subthalamic nucleus stimulation in Parkinson's disease: Are we jumping the gun? Eur J Neurol 16:440-441
93. Munro CA, McCaul ME, Wong DF, Oswald LM, Zhou Y, Brasic J, Kuwabara H, Kumar A, Alexander M, Ye W, Wand GS (2006) Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59:966-974
94. Muramatsu T, Higuchi S (1995) Dopamine transporter gene polymorphism and alcoholism. Biochem Biophys Res Commun 211(1):28-32
95. Neville MJ, Johnstone EC, Walton RT (2004) Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23(6):540-545 (Pubitemid 38720604)
96. Nielsen DA, Barral S, Proudnikov D, Kellogg S, Ho A, Ott J, Kreek MJ (2008) TPH2 and TPH1: Association of variants and interactions with heroin addiction. Behav Genet 38(2):133-150
97. O'Sullivan SS, Evans AH, Lees AJ (2009) Dopamine dysregulation syndrome: An overview of its epidemiology, mechanisms and management. CNS Drugs 23:157-170
98. Odiyoor M, Kobylecki C, Hackett RJ, Silverdale MA, Kellett MW (2009) Pramipexole and gender identity disorder: Expanding the phenotype of hypersexuality in Parkinson's disease. Mov Disord 24:2434-2435
99. Olmstead MC, Ouagazzal AM, Kieffer BL (2009) Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. PLoS One 4:e4410
100. Ouchi Y, Yoshikawa E, Okada H, Futatsubashi M, Sekine Y, Iyo M, Sakamoto M (1999) Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for beta-CFT binding with positron emission tomography. Ann Neurol 45:601-610 (Pubitemid 29217588)
101. Park HS, Kim SH, Bang SA, Yoon EJ, Cho SS, Kim SE (2010) Altered regional cerebral glucose metabolism in internet game overusers: A 18F- fluorodeoxyglucose positron emission tomography study. CNS Spectr 15:159-166
102. Petrovic P, Pleger B, Seymour B, Kloppel S, De Martino B, Critchley H, Dolan RJ (2008) Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses. J Neurosci 28:10509-10516
103. Pérez de Castro I, Ibáñez A, Torres P, Sáiz-Ruiz J, Fernández- Piqueras J (1997) Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. Pharmacogenetics 7(5):345-348 (Pubitemid 27427542)
104. Pérez de Castro I, Ibáñez A, Saiz-Ruiz J, Fernández-Piqueras J (1999) Genetic contribution to pathological gambling: Possible association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected men. Pharmacogenetics 9(3):397-400 (Pubitemid 29376385)
105. Pérez de Castro I, Ibáñez A, Saiz-Ruiz J, Fernández-Piqueras J (2002) Concurrent positive association between pathological gambling and functional DNA polymorphisms at the MAO-A and the 5-HT transporter genes. Mol Psychiatry 7(9):927-928 (Pubitemid 35333044)
106. Pinggera GM, Pichler R, Rehder P, Kerschbaumer A, Buttazzoni A, Zangerl F, Mitterberger M (2009) Penile strangulation in a patient with Parkinson's disease: A case report. Cases J 2:9379
107. Potenza MN (2001) The neurobiology of pathological gambling. Semin Clin Neuropsychiatry 6:217-226
108. Potenza MN (2008) Review. The neurobiology of pathological gambling and drug addiction: An overview and new findings. Philos Trans R Soc Lond B Biol Sci 363:3181-3189
109. Rabinak CA, Nirenberg MJ (2010) Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 67:58-63
110. Rao H, Korczykowski M, Pluta J, Hoang A, Detre JA (2008) Neural correlates of voluntary and involuntary risk taking in the humanbrain: An fMRI Study of the Balloon Analog Risk Task (BART). Neuroimage 42:902-910
111. Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, Weintraub D (2010) Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord 25:1660-1669
112. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C (2005) Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 8:147-148 (Pubitemid 40194043)
113. Riba J, Kramer UM, Heldmann M, Richter S, Munte TF (2008) Dopamine agonist increases risk taking but blunts reward-related brain activity. PLoS ONE 3:e2479
114. Robinson TE, Berridge KC (1993) The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291 (Pubitemid 23219500)
115. Rogers G, Joyce P, Mulder R, Sellman D, Miller A, Allington M et al (2004) Association of a duplicated repeat polymorphism in the 50-untranslated region of the DRD4 gene with novelty seeking. Am J Med Genet B Neuropsychiatr Genet 126B(1):95-98 (Pubitemid 38420129)
116. Rogers RD (2011) The roles of dopamine and serotonin in decision making: Evidence from pharmacological experiments in humans. Neuropsychopharmacology 36:114-132
117. Rotondo A, Bosco D, Plastino M, Consoli A, Bosco F (2010) Clozapine for medication-related pathological gambling in Parkinson disease. Mov Disord 25:1994-1995
118. Santangelo G, Vitale C, Trojano L, Verde F, Grossi D, Barone P (2009) Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Mov Disord 24:899-905
119. Schlesinger I, Erikh I, Zaaroor M (2010) Dopamine agonist withdrawal syndrome: The apomorphine solution. Arch Neurol 67:1155 (author reply 1156)
120. Schultz W (2002) Getting formal with dopamine and reward. Neuron 36:241-263 (Pubitemid 35217890)
121. Seedat S, Kesler S, Niehaus DJ, Stein DJ (2000) Pathological gambling behaviour: Emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety 11:185-186 (Pubitemid 30612771)
122. Shinohara M, Mizushima H, Hirano M, Shioe K, Nakazawa M, Hiejima Y et al (2004) Eating disorders with binge-eating behaviour are associated with the s allele of the 30-UTR VNTR polymorphism of the dopamine transporter gene. J Psychiatry Neurosci 29(2):134-137 (Pubitemid 38570218)
123. Singh-Curry V, Bunzeck N, O'Sullivan S, Molloy M, Perry R, Bain P, Lees A, Duzel E, Husain M (2010) PATH50 Novelty-seeking and risk-taking behaviour in subtypes of Parkinson's disease. J Neurol Neurosurg Psychiatry 81:e21
124. Siri C, Cilia R, De Gaspari D, Canesi M, Meucci N, Zecchinelli AL, Pezzoli G, Antonini A (2010) Cognitive status of patients with Parkinson's disease and pathological gambling. J Neurol 257:247-252
125. Smith KS, Tindell AJ, Aldridge JW, Berridge KC (2009) Ventral pallidum roles in reward and motivation. Behav Brain Res 196:155-167
126. Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, van Eimeren T, Rusjan P, Houle S, Strafella AP (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A [11C] raclopride PET study. Brain 132:1376-1385
127. Tamminga CA, Nestler EJ (2006) Pathological gambling: Focusing on the addiction, not the activity. Am J Psychiatry 163:180-181 (Pubitemid 44480834)
128. Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M (2010) Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol 68:400-404
129. Tom SM, Fox CR, Trepel C, Poldrack RA (2007) The neural basis of loss aversion in decision-making under risk. Science 315:515-518 (Pubitemid 46175755)
130. Tremblay L, Schultz W (1999) Relative reward preference in primate orbitofrontal cortex. Nature 398:704-708 (Pubitemid 29197648)
131. van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP (2009) Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: A trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology 34:2758-2766
132. van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TD, Houle S, Miyasaki JM, Zurowski M, Lang AE, Strafella AP (2010) Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 75:1711-1716
133. Volkmann J, Daniels C, Witt K (2010) Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 6:487-498
134. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N (2001) Low level of brain dopamine D2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015-2021 (Pubitemid 33104107)
135. Volkow ND, Wang GJ, Fowler JS, Telang F (2008) Overlapping neuronal circuits in addiction and obesity: Evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci 363:3191-3200
136. Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M (2007) Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64:212-216
137. Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ, Hallett M (2010) Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 65:135-142
138. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: A cross-sectional study of 3,090 patients. Arch Neurol 67:589-595
139. Witjas T, Baunez C, Henry JM, Delfini M, Regis J, Cherif AA, Peragut JC, Azulay JP (2005) Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation. Mov Disord 20:1052-1055 (Pubitemid 41419526)
140. Yacubian J, Glascher J, Schroeder K, Sommer T, Braus DF, Buchel C (2006) Dissociable systems for gain- and loss-related value predictions and errors of prediction in the human brain. J Neurosci 26:9530-9537 (Pubitemid 44396866)
141. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J (2007) Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Genet 16(23):2844-2853 (Pubitemid 350048383)